Skip to content
OpenCapital
Get started

NeoGenomics NEO Sales & Marketing

Sales & Marketing at other companies

Guardant Health logo
Guardant HealthGH
$169.13M+62.1%
CareDx logo
CareDxCDNA
$30.37M+32.1%
Veracyte logo
VeracyteVCYT
$27.16M+11.0%

Segments

By segment

See full
Reportable Segment$23.48M+8.1%

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.68B+86.5%
Enterprise value$1.6B+159%
P/S2.3×+0.9×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%—

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's sales & marketing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's sales & marketing?
NeoGenomics (NEO) reported sales & marketing of $23.83M in Q1 2026.
How has NeoGenomics's sales & marketing changed year-over-year?
NeoGenomics's sales & marketing increased by 5.1% year-over-year, from $22.68M to $23.83M.
What is the long-term trend for NeoGenomics's sales & marketing?
Over 4 years (2021 to 2025), NeoGenomics's sales & marketing has grown at a 10.1% compound annual growth rate (CAGR), from $62.59M to $92.01M.
What does sales & marketing mean?
Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.